N-({[4-(aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide

This compound is a small molecule belonging to the class of benzenesulfonamides, characterized by containing sulfonamide groups. It has a molecular formula of C14H15N3O5S2 and an average molecular weight of approximately 369.42 g/mol. The drug is experimental and not approved for clinical use in any country. It has no known patents or indicated conditions, and no clinical trials beyond phase 0 have been reported. Mechanistically, it acts as an inhibitor of carbonic anhydrase 2 (CA II), with a reported binding affinity (Ki) around 12 nM, indicating potent inhibition activity against this enzyme. Carbonic anhydrase inhibitors are typically used to modulate pH balance and fluid secretion in various tissues but specific therapeutic indications for this compound are not established. No developer or manufacturer information is available publicly, reflecting its experimental status.

Other names

N-({[4-(aminosulfonyl)phenyl]amino}carbonyl)-4-methylbenzenesulfonamide